The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Ocular Drug Delivery-Global Market Insights and Sales Trends 2025
Synopsis
The global Ocular Drug Delivery market size is expected to reach US$ 35220 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of Ocular Drug Delivery in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers, Ophthalmic Clinics and Homecare Settings, are propelling Ocular Drug Delivery market. Ocular Insert, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Iontophoresis segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Ocular Drug Delivery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Ocular Drug Delivery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Ocular Drug Delivery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Ocular Drug Delivery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Ocular Drug Delivery covered in this report include OCULAR THERAPEUTIX, INC, Alimera Sciences, Allergan, Plc, EyeGate Pharma, Valeant Pharmaceuticals International, Inc, Envisia Therapeutics, Clearside Biomedical, Graybug Vision Inc and Taiwan Liposome Company, etc.
The global Ocular Drug Delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
OCULAR THERAPEUTIX, INC
Alimera Sciences
Allergan, Plc
EyeGate Pharma
Valeant Pharmaceuticals International, Inc
Envisia Therapeutics
Clearside Biomedical
Graybug Vision Inc
Taiwan Liposome Company
Santen Pharmaceutical
Global Ocular Drug Delivery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ocular Drug Delivery market, Segment by Type:
Ocular Insert
Iontophoresis
Intraocular Implants
In Situ Gel & Punctal Plugs
Others
Global Ocular Drug Delivery market, by Application
Hospitals
Ambulatory Surgical Centers
Ophthalmic Clinics
Homecare Settings
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Ocular Drug Delivery manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Ocular Drug Delivery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Ocular Drug Delivery market size is expected to reach US$ 35220 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of Ocular Drug Delivery in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers, Ophthalmic Clinics and Homecare Settings, are propelling Ocular Drug Delivery market. Ocular Insert, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Iontophoresis segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Ocular Drug Delivery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Ocular Drug Delivery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Ocular Drug Delivery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Ocular Drug Delivery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Ocular Drug Delivery covered in this report include OCULAR THERAPEUTIX, INC, Alimera Sciences, Allergan, Plc, EyeGate Pharma, Valeant Pharmaceuticals International, Inc, Envisia Therapeutics, Clearside Biomedical, Graybug Vision Inc and Taiwan Liposome Company, etc.
The global Ocular Drug Delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
OCULAR THERAPEUTIX, INC
Alimera Sciences
Allergan, Plc
EyeGate Pharma
Valeant Pharmaceuticals International, Inc
Envisia Therapeutics
Clearside Biomedical
Graybug Vision Inc
Taiwan Liposome Company
Santen Pharmaceutical
Global Ocular Drug Delivery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ocular Drug Delivery market, Segment by Type:
Ocular Insert
Iontophoresis
Intraocular Implants
In Situ Gel & Punctal Plugs
Others
Global Ocular Drug Delivery market, by Application
Hospitals
Ambulatory Surgical Centers
Ophthalmic Clinics
Homecare Settings
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Ocular Drug Delivery manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Ocular Drug Delivery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Ocular Drug Delivery Market Overview
1.1 Ocular Drug Delivery Product Overview
1.2 Ocular Drug Delivery Market Segment by Type
1.2.1 Ocular Insert
1.2.2 Iontophoresis
1.2.3 Intraocular Implants
1.2.4 In Situ Gel & Punctal Plugs
1.2.5 Others
1.3 Global Ocular Drug Delivery Market Size by Type
1.3.1 Global Ocular Drug Delivery Market Size Overview by Type (2018-2029)
1.3.2 Global Ocular Drug Delivery Historic Market Size Review by Type (2018-2023)
1.3.3 Global Ocular Drug Delivery Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Ocular Drug Delivery Sales Breakdown by Type (2018-2023)
1.4.2 Europe Ocular Drug Delivery Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Ocular Drug Delivery Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Ocular Drug Delivery Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Ocular Drug Delivery Sales Breakdown by Type (2018-2023)
2 Global Ocular Drug Delivery Market Competition by Company
2.1 Global Top Players by Ocular Drug Delivery Sales (2018-2023)
2.2 Global Top Players by Ocular Drug Delivery Revenue (2018-2023)
2.3 Global Top Players by Ocular Drug Delivery Price (2018-2023)
2.4 Global Top Manufacturers Ocular Drug Delivery Manufacturing Base Distribution, Sales Area, Product Type
2.5 Ocular Drug Delivery Market Competitive Situation and Trends
2.5.1 Ocular Drug Delivery Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Ocular Drug Delivery Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ocular Drug Delivery as of 2022)
2.7 Date of Key Manufacturers Enter into Ocular Drug Delivery Market
2.8 Key Manufacturers Ocular Drug Delivery Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Ocular Drug Delivery Status and Outlook by Region
3.1 Global Ocular Drug Delivery Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Ocular Drug Delivery Historic Market Size by Region
3.2.1 Global Ocular Drug Delivery Sales in Volume by Region (2018-2023)
3.2.2 Global Ocular Drug Delivery Sales in Value by Region (2018-2023)
3.2.3 Global Ocular Drug Delivery Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Ocular Drug Delivery Forecasted Market Size by Region
3.3.1 Global Ocular Drug Delivery Sales in Volume by Region (2024-2029)
3.3.2 Global Ocular Drug Delivery Sales in Value by Region (2024-2029)
3.3.3 Global Ocular Drug Delivery Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Ocular Drug Delivery by Application
4.1 Ocular Drug Delivery Market Segment by Application
4.1.1 Hospitals
4.1.2 Ambulatory Surgical Centers
4.1.3 Ophthalmic Clinics
4.1.4 Homecare Settings
4.2 Global Ocular Drug Delivery Market Size by Application
4.2.1 Global Ocular Drug Delivery Market Size Overview by Application (2018-2029)
4.2.2 Global Ocular Drug Delivery Historic Market Size Review by Application (2018-2023)
4.2.3 Global Ocular Drug Delivery Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Ocular Drug Delivery Sales Breakdown by Application (2018-2023)
4.3.2 Europe Ocular Drug Delivery Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Ocular Drug Delivery Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Ocular Drug Delivery Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Ocular Drug Delivery Sales Breakdown by Application (2018-2023)
5 North America Ocular Drug Delivery by Country
5.1 North America Ocular Drug Delivery Historic Market Size by Country
5.1.1 North America Ocular Drug Delivery Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Ocular Drug Delivery Sales in Volume by Country (2018-2023)
5.1.3 North America Ocular Drug Delivery Sales in Value by Country (2018-2023)
5.2 North America Ocular Drug Delivery Forecasted Market Size by Country
5.2.1 North America Ocular Drug Delivery Sales in Volume by Country (2024-2029)
5.2.2 North America Ocular Drug Delivery Sales in Value by Country (2024-2029)
6 Europe Ocular Drug Delivery by Country
6.1 Europe Ocular Drug Delivery Historic Market Size by Country
6.1.1 Europe Ocular Drug Delivery Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Ocular Drug Delivery Sales in Volume by Country (2018-2023)
6.1.3 Europe Ocular Drug Delivery Sales in Value by Country (2018-2023)
6.2 Europe Ocular Drug Delivery Forecasted Market Size by Country
6.2.1 Europe Ocular Drug Delivery Sales in Volume by Country (2024-2029)
6.2.2 Europe Ocular Drug Delivery Sales in Value by Country (2024-2029)
7 Asia-Pacific Ocular Drug Delivery by Region
7.1 Asia-Pacific Ocular Drug Delivery Historic Market Size by Region
7.1.1 Asia-Pacific Ocular Drug Delivery Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Ocular Drug Delivery Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Ocular Drug Delivery Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Ocular Drug Delivery Forecasted Market Size by Region
7.2.1 Asia-Pacific Ocular Drug Delivery Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Ocular Drug Delivery Sales in Value by Region (2024-2029)
8 Latin America Ocular Drug Delivery by Country
8.1 Latin America Ocular Drug Delivery Historic Market Size by Country
8.1.1 Latin America Ocular Drug Delivery Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Ocular Drug Delivery Sales in Volume by Country (2018-2023)
8.1.3 Latin America Ocular Drug Delivery Sales in Value by Country (2018-2023)
8.2 Latin America Ocular Drug Delivery Forecasted Market Size by Country
8.2.1 Latin America Ocular Drug Delivery Sales in Volume by Country (2024-2029)
8.2.2 Latin America Ocular Drug Delivery Sales in Value by Country (2024-2029)
9 Middle East and Africa Ocular Drug Delivery by Country
9.1 Middle East and Africa Ocular Drug Delivery Historic Market Size by Country
9.1.1 Middle East and Africa Ocular Drug Delivery Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Ocular Drug Delivery Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Ocular Drug Delivery Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Ocular Drug Delivery Forecasted Market Size by Country
9.2.1 Middle East and Africa Ocular Drug Delivery Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Ocular Drug Delivery Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 OCULAR THERAPEUTIX, INC
10.1.1 OCULAR THERAPEUTIX, INC Company Information
10.1.2 OCULAR THERAPEUTIX, INC Introduction and Business Overview
10.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.1.4 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Products Offered
10.1.5 OCULAR THERAPEUTIX, INC Recent Development
10.2 Alimera Sciences
10.2.1 Alimera Sciences Company Information
10.2.2 Alimera Sciences Introduction and Business Overview
10.2.3 Alimera Sciences Ocular Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Alimera Sciences Ocular Drug Delivery Products Offered
10.2.5 Alimera Sciences Recent Development
10.3 Allergan, Plc
10.3.1 Allergan, Plc Company Information
10.3.2 Allergan, Plc Introduction and Business Overview
10.3.3 Allergan, Plc Ocular Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Allergan, Plc Ocular Drug Delivery Products Offered
10.3.5 Allergan, Plc Recent Development
10.4 EyeGate Pharma
10.4.1 EyeGate Pharma Company Information
10.4.2 EyeGate Pharma Introduction and Business Overview
10.4.3 EyeGate Pharma Ocular Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.4.4 EyeGate Pharma Ocular Drug Delivery Products Offered
10.4.5 EyeGate Pharma Recent Development
10.5 Valeant Pharmaceuticals International, Inc
10.5.1 Valeant Pharmaceuticals International, Inc Company Information
10.5.2 Valeant Pharmaceuticals International, Inc Introduction and Business Overview
10.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Products Offered
10.5.5 Valeant Pharmaceuticals International, Inc Recent Development
10.6 Envisia Therapeutics
10.6.1 Envisia Therapeutics Company Information
10.6.2 Envisia Therapeutics Introduction and Business Overview
10.6.3 Envisia Therapeutics Ocular Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Envisia Therapeutics Ocular Drug Delivery Products Offered
10.6.5 Envisia Therapeutics Recent Development
10.7 Clearside Biomedical
10.7.1 Clearside Biomedical Company Information
10.7.2 Clearside Biomedical Introduction and Business Overview
10.7.3 Clearside Biomedical Ocular Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Clearside Biomedical Ocular Drug Delivery Products Offered
10.7.5 Clearside Biomedical Recent Development
10.8 Graybug Vision Inc
10.8.1 Graybug Vision Inc Company Information
10.8.2 Graybug Vision Inc Introduction and Business Overview
10.8.3 Graybug Vision Inc Ocular Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Graybug Vision Inc Ocular Drug Delivery Products Offered
10.8.5 Graybug Vision Inc Recent Development
10.9 Taiwan Liposome Company
10.9.1 Taiwan Liposome Company Company Information
10.9.2 Taiwan Liposome Company Introduction and Business Overview
10.9.3 Taiwan Liposome Company Ocular Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Taiwan Liposome Company Ocular Drug Delivery Products Offered
10.9.5 Taiwan Liposome Company Recent Development
10.10 Santen Pharmaceutical
10.10.1 Santen Pharmaceutical Company Information
10.10.2 Santen Pharmaceutical Introduction and Business Overview
10.10.3 Santen Pharmaceutical Ocular Drug Delivery Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Santen Pharmaceutical Ocular Drug Delivery Products Offered
10.10.5 Santen Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Ocular Drug Delivery Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Ocular Drug Delivery Industrial Chain Analysis
11.4 Ocular Drug Delivery Market Dynamics
11.4.1 Ocular Drug Delivery Industry Trends
11.4.2 Ocular Drug Delivery Market Drivers
11.4.3 Ocular Drug Delivery Market Challenges
11.4.4 Ocular Drug Delivery Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Ocular Drug Delivery Distributors
12.3 Ocular Drug Delivery Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
